The SMILE trial will seek to identify individuals at high risk for developing lupus and treat them before they ever transition into the disease.
The deadline for the eight-week summer program is Feb. 1.
Morris Reichlin helped build OMRF into one of the world’s leading centers for lupus research and treatment.
These findings will help scientists understand how to better diagnose and treat the disease.
The foundation hopes to recruit up to 2,000 healthy individuals.
OBI’s new software system, Bio-Linked, will be used to match willing blood donors with researchers at OMRF to build a volunteer group for StopRA.